Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...
The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.
In a breakthrough that defies nature, Northwestern University and Stanford University synthetic biologists have created a new ...
A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless.
Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...
PALI-2108 is the first and only PDE4 inhibitor in development targeting the terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...
Interesting Engineering on MSN
Synthetic metabolism offers new way to convert CO2 into usable industrial materials
Scientists build a synthetic metabolism that converts CO2-derived formate into valuable chemicals outside living cells.
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Natural biological systems cannot efficiently convert waste CO₂ or its derivatives into useful building-block chemicals at a scale that can keep pace with rising atmospheric carbon. Engineer a fully ...
At the same table, with the same drinks, women often get drunk faster than men — and alcohol can affect women's brains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback